Hepatitis C infection and presence of advanced fibrosis: Wait or treat? Why wait? There is no time to lose, is there?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepatitis C infection and presence of advanced fibrosis: Wait or treat? Why wait? There is no time to lose, is there?

Published:2013-03 Issue:3 Volume:58 Page:412-414
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Tillmann Hans Ludger

Publisher

Elsevier BV

Subject

Hepatology

Reference30 articles.

1. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation;Bock;Gastroenterology,2002

2. Lamivudine as initial treatment for chronic hepatitis B in the United States;Dienstag;N Engl J Med,1999

3. Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B;Murray;Hepatology,2012

4. A randomized, double-blind, placebo-controlled trial of recombinant human alpha-interferon therapy for chronic non-A, non-B (type C) hepatitis;Di Bisceglie;J Hepatol,1990

5. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group;McHutchison;N Engl J Med,1998

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers of Hepatic Fibrosis in Chronic Hepatitis C;Journal of Clinical Gastroenterology;2017-03

2. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation;Health Technology Assessment;2015-01

3. Effect of the Hepatitis C Virus Protease Inhibitor Faldaprevir on the Pharmacokinetics of an Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel in Healthy Female Volunteers;Antimicrobial Agents and Chemotherapy;2014-11-10

4. Usefulness of Lead-In phase in determining risk/benefit of telaprevir treatment in patients with HCV cirrhosis;Journal of Hepatology;2013-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3